Medication Cost Is an Adherence Problem

For many patients on hormone replacement therapy, the decision to start Climara (Estradiol transdermal patch) isn't the hard part — it's the decision to keep filling the prescription month after month. When out-of-pocket costs climb, adherence drops. Patients skip patches, stretch them beyond seven days, or discontinue therapy entirely — often without telling their provider.

A 2023 study published in Menopause found that cost was among the top three reasons women cited for discontinuing HRT. As providers, we can't control drug pricing, but we can make sure our patients know about every available option to reduce their costs.

This guide covers the savings programs, generic alternatives, and cost conversation strategies that can help your patients stay on their prescribed therapy.

What Patients Are Paying

Understanding the current price landscape helps frame the conversation:

• Brand-name Climara (cash price): $120–$180 per month for 4 patches (one month supply)
• Generic Estradiol patch, once-weekly (cash price): $80–$120 per month without discounts
• Generic Estradiol patch with discount card: $55–$80 per month (GoodRx, SingleCare, Optum Perks)
• With commercial insurance: $10–$50 per month (generic usually Tier 2; brand may require prior authorization or Tier 3 copay)
• Medicare Part D: Covered with varying copays; patients in the coverage gap may pay significantly more

The gap between what patients expect to pay and what they actually pay at the pharmacy counter is often where adherence breaks down. A patient who was quoted a $20 copay during an office visit may face a $75 charge at the register if their plan changed, or if the pharmacy fills brand instead of generic.

Manufacturer Savings Programs

Bayer Patient Assistance Program

Bayer, the manufacturer of Climara, offers a Patient Assistance Program (PAP) for uninsured and underinsured patients who meet income eligibility requirements:

• Phone: 1-866-575-5002
• Eligibility: Uninsured or underinsured patients with demonstrated financial need
• Coverage: May provide Climara at no cost to qualifying patients
• Application: Requires a healthcare provider's involvement — the patient or provider calls with the provider's fax/phone number and a contact name at the office

For patients using Climara Pro (the combination Estradiol/Levonorgestrel patch), Bayer offers a separate savings card available at climarapro.com. This card is available for commercially insured patients only and is not valid for Medicare, Medicaid, TRICARE, VA, or FEHBP beneficiaries.

What Providers Can Do

• Keep Bayer PAP applications accessible in your office or within your EHR's patient resources
• Designate a staff member to help patients initiate the application process
• Follow up at the next visit to confirm enrollment was successful

Coupon and Discount Cards

For patients with commercial insurance who face high copays — or uninsured patients who don't qualify for PAP — free prescription discount cards can significantly reduce costs on generic Estradiol patches:

• GoodRx — Often shows generic Estradiol patch prices starting around $55–$80 for 4 patches. Patients can compare prices across pharmacies and show the coupon at pickup.
• SingleCare — Similar savings; prices may vary by pharmacy
• Optum Perks — Another free discount card option with pharmacy-specific pricing
• RxSaver — Compares prices across major chains and independent pharmacies
• BuzzRx, America's Pharmacy, CareCard — Additional options worth checking

Important notes for your practice:

• Discount cards cannot be combined with insurance — they are an alternative to insurance pricing, not a supplement
• They work best for generic medications; brand-name Climara savings are minimal through these cards
• Prices vary by pharmacy — encourage patients to compare using the card's website or app before filling
• These cards are free and don't require enrollment or personal health information

Generic Alternatives and Therapeutic Substitution

The most impactful cost-saving measure for most patients is switching from brand-name Climara to a generic Estradiol transdermal patch.

Once-Weekly Generic Options

Two manufacturers produce FDA-approved generic equivalents to Climara (AB-rated, once-weekly application):

• Mylan Technologies — Approved since 2000; available in all six Climara strengths (0.025, 0.0375, 0.05, 0.06, 0.075, 0.1 mg/day)
• Zydus Pharmaceuticals — Approved March 2023; also available in all six strengths

These generics contain the same active ingredient, same delivery mechanism, and same once-weekly application schedule as brand Climara.

Twice-Weekly Alternatives

If once-weekly generics are unavailable (as may happen during the ongoing Estradiol patch shortage), consider switching to twice-weekly Estradiol patches:

• Vivelle-Dot (brand) or generic equivalent — Applied twice weekly
• Dotti — Twice-weekly generic Estradiol patch
• Minivelle — Twice-weekly, smaller patch size

When switching between once-weekly and twice-weekly patches, match the daily Estradiol delivery rate (e.g., Climara 0.05 mg/day → Vivelle-Dot 0.05 mg applied twice weekly). The total weekly Estradiol exposure should remain equivalent.

Non-Patch Alternatives

For patients who have difficulty with patch adhesion, skin irritation, or who prefer a different formulation:

• Oral Estradiol (Estrace, generic) — Often the least expensive option ($4–$15/month at many pharmacies). Trade-off: higher first-pass hepatic metabolism may increase blood clot and triglyceride risk.
• Estradiol gel (Divigel, EstroGel, generic) — Transdermal delivery (bypasses liver) but requires daily application
• Estradiol spray (Evamist) — Transdermal, daily use

For a complete overview of alternatives, see our article on alternatives to Climara.

Patient Assistance Programs (Third-Party)

For patients who are uninsured, underinsured, or facing financial hardship, several third-party organizations can help:

• NeedyMeds (needymeds.org) — Database of patient assistance programs, discount drug cards, and disease-based assistance
• RxAssist (rxassist.org) — Comprehensive directory of pharmaceutical company PAPs
• RxHope (rxhope.com) — Helps connect patients with manufacturer assistance programs

These resources are free to use and can be a lifeline for patients who fall through the cracks of insurance coverage.

Building Cost Conversations Into Your Workflow

Cost discussions are most effective when they're proactive rather than reactive. Here are practical ways to integrate them:

At the Point of Prescribing

• Default to generic when appropriate. Write prescriptions for "Estradiol transdermal patch" rather than "Climara" unless there's a clinical reason for the brand.
• State the expected cost range. "This medication typically costs $55–$80 per month with a discount card, or your insurance copay may be lower."
• Ask about financial concerns directly. "Is cost going to be a factor for you? If so, let's talk about options now rather than at the pharmacy."

At Follow-Up Visits

• Ask about adherence — and probe for cost barriers. "Have you been using your patch every week as prescribed? Has the cost been manageable?"
• Review insurance changes. Patients may switch plans annually. What was affordable last year may not be this year.
• Update savings resources. Discount card pricing and PAP eligibility can change. A patient who didn't qualify last year may qualify now.

For Your Staff

• Train front-desk and nursing staff to provide discount card information (GoodRx, SingleCare) during checkout
• Keep printed materials about the Bayer PAP and third-party assistance programs in exam rooms or the waiting area
• Use your EHR to flag patients with high copays or prior authorization denials for proactive outreach

Helping Patients Find Climara in Stock

Cost savings don't matter if patients can't find the medication at all. During the current Estradiol patch shortage, direct patients to Medfinder for Providers to help locate pharmacies with Climara or generic Estradiol patches in stock. You can also review our provider's guide to helping patients find Climara in stock for additional strategies.

Final Thoughts

Medication cost is a modifiable barrier to adherence. When providers proactively address pricing, offer generic alternatives, and connect patients with savings programs, adherence improves and outcomes follow. The tools exist — manufacturer programs, discount cards, generic equivalents, and third-party assistance — they just need a champion in the exam room to make sure patients know about them.

For more Climara resources for your practice, visit Medfinder for Providers.